|
AP3S1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.108300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.750300E-02 |
| Normal-vs-Stage2 |
4.049000E-01 |
| Normal-vs-Stage3 |
1.065610E-01 |
| Normal-vs-Stage4 |
2.989900E-02 |
| Stage1-vs-Stage2 |
3.689700E-02 |
| Stage1-vs-Stage3 |
8.104400E-01 |
| Stage1-vs-Stage4 |
3.130400E-01 |
| Stage2-vs-Stage3 |
3.809700E-02 |
| Stage2-vs-Stage4 |
1.514010E-02 |
| Stage3-vs-Stage4 |
4.310600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.070000E-02 |
| Normal-vs-AfricanAmerican |
8.346800E-01 |
| Normal-vs-Asian |
3.945600E-01 |
| Caucasian-vs-AfricanAmerican |
1.751410E-01 |
| Caucasian-vs-Asian |
6.054200E-01 |
| AfricanAmerican-vs-Asian |
5.611400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.196000E-02 |
| Normal-vs-Female |
2.199600E-01 |
| Male-vs-Female |
1.182980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.333700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.452560E-01 |
| Normal-vs-Age(61-80Yrs) |
8.338600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.400000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.879200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.763900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.246800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.080240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.326800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.270430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.142300E-02 |
| Classical-VS-Follicular |
4.52689996599531E-10 |
| Classical-VS-Other |
8.667800E-01 |
| Classical-VS-Normal |
3.880200E-03 |
| Tall-VS-Follicular |
4.92189999978798E-07 |
| Tall-VS-Other |
6.740800E-01 |
| Tall-VS-Normal |
9.404900E-04 |
| Follicular-VS-Other |
1.973830E-01 |
| Follicular-VS-Normal |
9.739600E-03 |
| Other-VS-Normal |
4.775800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.478200E-01 |
| Normal-vs-N1 |
9.401800E-02 |
| N0-vs-N1 |
1.821560E-02 |
|
|
